MXPA05010413A - Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona. - Google Patents

Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona.

Info

Publication number
MXPA05010413A
MXPA05010413A MXPA05010413A MXPA05010413A MXPA05010413A MX PA05010413 A MXPA05010413 A MX PA05010413A MX PA05010413 A MXPA05010413 A MX PA05010413A MX PA05010413 A MXPA05010413 A MX PA05010413A MX PA05010413 A MXPA05010413 A MX PA05010413A
Authority
MX
Mexico
Prior art keywords
preparing
polymorph
rosiglitazone maleate
compound
rosiglitazone
Prior art date
Application number
MXPA05010413A
Other languages
English (en)
Spanish (es)
Inventor
Michael John Sasse
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MXPA05010413A publication Critical patent/MXPA05010413A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA05010413A 2003-03-28 2004-03-25 Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona. MXPA05010413A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307259.2A GB0307259D0 (en) 2003-03-28 2003-03-28 Process
PCT/GB2004/001306 WO2004085435A1 (en) 2003-03-28 2004-03-25 Process for preparing a polymorph of rosiglitazone maleate

Publications (1)

Publication Number Publication Date
MXPA05010413A true MXPA05010413A (es) 2005-11-04

Family

ID=9955778

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010413A MXPA05010413A (es) 2003-03-28 2004-03-25 Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona.

Country Status (18)

Country Link
US (1) US20070167494A1 (https=)
EP (1) EP1615918A1 (https=)
JP (1) JP2006521340A (https=)
KR (1) KR20050120670A (https=)
CN (1) CN1768057A (https=)
AU (2) AU2004224068A1 (https=)
BR (1) BRPI0408752A (https=)
CA (1) CA2520249A1 (https=)
EA (1) EA009331B1 (https=)
EC (1) ECSP056038A (https=)
GB (1) GB0307259D0 (https=)
IS (1) IS8087A (https=)
MA (1) MA27727A1 (https=)
MX (1) MXPA05010413A (https=)
NO (1) NO20054911L (https=)
OA (1) OA13042A (https=)
WO (1) WO2004085435A1 (https=)
ZA (1) ZA200507100B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
CA3051830A1 (en) 2017-01-27 2018-08-02 Neurocrine Bioscienes, Inc. Methods for the administration of certain vmat2 inhibitors
CA3076000A1 (en) 2017-09-21 2019-03-28 Neurocrine Biosciences, Inc. High dosage valbenazine formulation and compositions, methods, and kits related thereto
JP2021502959A (ja) 2017-10-10 2021-02-04 ニューロクライン バイオサイエンシーズ,インコーポレイテッド 特定のvmat2インヒビターを投与するための方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
WO2000064893A2 (en) * 1999-04-23 2000-11-02 Smithkline Beecham Plc Thiazolidinedione derivative and its use as antidiabetic
EP1903043A1 (en) * 1999-04-23 2008-03-26 SmithKline Beecham P.L.C. Novel pharmaceutical
UA67844C2 (uk) * 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
CZ2003864A3 (cs) * 2000-09-26 2004-01-14 Dr. Reddy´S Research Foundation Nové polymorfní formy 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidin-2,4-dion-maleátu a způsob jejich přípravy

Also Published As

Publication number Publication date
EP1615918A1 (en) 2006-01-18
WO2004085435A1 (en) 2004-10-07
OA13042A (en) 2006-11-10
ZA200507100B (en) 2006-07-26
GB0307259D0 (en) 2003-05-07
MA27727A1 (fr) 2006-01-02
JP2006521340A (ja) 2006-09-21
EA009331B1 (ru) 2007-12-28
AU2008237610A1 (en) 2008-11-27
AU2004224068A1 (en) 2004-10-07
CA2520249A1 (en) 2004-10-07
EA200501527A1 (ru) 2006-02-24
IS8087A (is) 2005-10-24
KR20050120670A (ko) 2005-12-22
CN1768057A (zh) 2006-05-03
BRPI0408752A (pt) 2006-03-28
US20070167494A1 (en) 2007-07-19
ECSP056038A (es) 2006-01-27
NO20054911L (no) 2005-10-24

Similar Documents

Publication Publication Date Title
EP1354987A4 (en) MONOCRYSTAL OF SILICON CARBIDE AND METHOD AND DEVICE FOR PRODUCING SAME
IL169146A0 (en) Process for the production of 2'-branched nucleosides
PL375409A1 (en) Method for preparing 3-halo-4,5-dihydro-1 i h /i -pyrazoles
ZA200410000B (en) Method for producing C13-alcohol mixtures
ZA200705125B (en) Crystalline forms of (r)-8-chloro-1-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
MXPA05010413A (es) Procedimiento para la preparacion de un polimorfo de maleato de rosiglitazona.
TWI328006B (en) Crystal form of quinoline compound and process for its production
WO2004043920A8 (en) Polymorphs of bicifadine hydrochloride
WO2005061493A3 (en) Polymorphic form b2 of ziprasidone base
WO2005000242A3 (en) Process for making polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]butyric acid
WO2006023659A3 (en) Novel polymorphs of azabicyclohexane
PL374503A1 (en) Process for preparing crystalline form i of cabergoline
TWI262969B (en) Method for growth of silicon carbide single crystal, silicon carbide seed crystal, and silicon carbide single crystal
TW200617224A (en) Production process of periodic table group 13 metal nitride crystal and production method of semiconductor device using the same
IL163779A0 (en) Process for preparing crystalline form i of cabergoline
IL197970A (en) Process for making piperidinyl-sulfanyl-acetyl-motilines
TW200505932A (en) Apparatus for producing fluoride crystal
PT1948626E (pt) Processo para a preparação de delmopinol e de seus derivados
EP1780203A3 (en) Enantioselective alkylation of tricyclic compounds
WO2004016589A3 (en) Process for production of highly pure donepezil hydrochloride
AU2003259002A1 (en) Process for manufacturing crystals of growth hormone
TW200517531A (en) Compound semiconductor single crystal and production process thereof
ZA200504954B (en) Process for the production of 2'-branched nucleosides
KR200358578Y1 (ko) 승화법에 의한 탄화규소 단결정시 사용되는 분리형 시드 홀더
AU2003226448A1 (en) Production method of 2,6-dihalopurine